Mirae Asset Global ETFs Holdings’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$103K Buy
15,388
+589
+4% +$3.96K ﹤0.01% 2598
2025
Q1
$134K Buy
14,799
+624
+4% +$5.64K ﹤0.01% 2498
2024
Q4
$245K Buy
14,175
+608
+4% +$10.5K ﹤0.01% 2281
2024
Q3
$217K Buy
13,567
+2,178
+19% +$34.8K ﹤0.01% 2341
2024
Q2
$162K Buy
+11,389
New +$162K ﹤0.01% 2362